AR123157A1 - BTK INHIBITORS - Google Patents
BTK INHIBITORSInfo
- Publication number
- AR123157A1 AR123157A1 ARP210102187A ARP210102187A AR123157A1 AR 123157 A1 AR123157 A1 AR 123157A1 AR P210102187 A ARP210102187 A AR P210102187A AR P210102187 A ARP210102187 A AR P210102187A AR 123157 A1 AR123157 A1 AR 123157A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutically acceptable
- compounds
- acceptable salts
- btk inhibitors
- pharmaceutical compositions
- Prior art date
Links
Abstract
Se proporcionan compuestos de fórmula (1) o sales farmacéuticamente aceptables de estos, en donde R¹, R², R³, R⁴, R⁵, R⁷, R⁸, R⁹, A¹, A², Q¹, Q², Q³, A, Z, m y n son como se definen en el presente documento; composiciones farmacéuticas que comprenden dichos compuestos o sales farmacéuticamente aceptables de estos y excipientes farmacéuticamente aceptables; y métodos para tratar un trastorno que responde a la inhibición de la tirosina cinasa de Bruton utilizando dichos compuestos, o sales farmacéuticamente aceptables de estos, o dichas composiciones farmacéuticas.Compounds of formula (1) or pharmaceutically acceptable salts thereof are provided, wherein R¹, R², R³, R⁴, R⁵, R⁷, R⁸, R⁹, A¹, A², Q¹, Q², Q³, A, Z, m and n are as are defined in this document; pharmaceutical compositions comprising said compounds or pharmaceutically acceptable salts thereof and pharmaceutically acceptable excipients; and methods of treating a disorder responsive to Bruton's tyrosine kinase inhibition using said compounds, or pharmaceutically acceptable salts thereof, or said pharmaceutical compositions.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063063188P | 2020-08-07 | 2020-08-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR123157A1 true AR123157A1 (en) | 2022-11-02 |
Family
ID=84578013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP210102187A AR123157A1 (en) | 2020-08-07 | 2021-08-05 | BTK INHIBITORS |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR123157A1 (en) |
-
2021
- 2021-08-05 AR ARP210102187A patent/AR123157A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1118969T1 (en) | Pyrimidine-2-amine compounds and their use as JAK kinase inhibitors | |
| CL2020002146A1 (en) | N- (phenyl) -2- (phenyl) pyrimidine-4-carboxamide derivatives and related compounds as hpki inhibitors to treat cancer. | |
| EA201991399A1 (en) | AMINOTRIAZOLOPYRIDINE COMPOUNDS AND THEIR APPLICATION IN TREATMENT OF CANCER | |
| PE20190336A1 (en) | NEW AMMONIUM DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
| BR112016016844A2 (en) | HETEROCYCLIC COMPOUNDS | |
| AR111233A1 (en) | TYK2 INHIBITORS, USES AND METHODS FOR THE PRODUCTION OF THE SAME | |
| CO2022015638A2 (en) | Compounds, pharmaceutical compositions and methods for the preparation of compounds and for their use | |
| PE20151981A1 (en) | ZESTE APPROVAL INHIBITOR PONTENCER | |
| NI201200184A (en) | MORPHOLINOPYRIMIDINES AND THEIR USE IN THERAPY | |
| EA201101566A1 (en) | IMIDAZOL DERIVATIVES AND THEIR APPLICATION AS CYLIN-dependent KINAZ MODULATORS | |
| BR112021023824A2 (en) | DNA-dependent protein kinase inhibitor | |
| PE20151601A1 (en) | NOVEL PYRIMIDINE AND PYRIDINE COMPOUNDS AND THEIR USE | |
| BR112019021853A2 (en) | VMAT2 INHIBITOR COMPOUNDS AND COMPOSITIONS OF THE SAME | |
| CL2022003045A1 (en) | Heteroaromatic Macrocyclic Ether Chemotherapeutics Related Applications | |
| BR112022024729A2 (en) | FIBROBLAST GROWTH FACTOR RECEPTOR KINASE INHIBITORS | |
| CO2021002976A2 (en) | 5- to 7-membered heterocyclic amides as jak inhibitors | |
| UY38233A (en) | INHIBITING AGENTS FOR BRUTON TYROSINE KINASE | |
| CO2022001853A2 (en) | Substituted 2-morpholinopyridine derivatives as inhibitors of atr kinase | |
| BR112019004248A2 (en) | dopamine b-hydroxylase inhibitors | |
| ECSP088257A (en) | AMIDA DERIVATIVES | |
| AR114082A1 (en) | PI4KIIIb INHIBITORS | |
| UY39517A (en) | BTK INHIBITORS | |
| AR121483A1 (en) | CRYSTALLINE HYDRATE OF A JAK INHIBITOR COMPOUND | |
| CL2022002975A1 (en) | Compounds and compositions for inhibiting hif2-alpha activity and their methods of use | |
| CO2022012884A2 (en) | Fused Amino Pyrimidine Compounds |